Healthcare Services

Pulmonary Embolism Market Industry Analysis Covering Trends, Drivers, And Future Outlook

June 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Value Outlook For The Pulmonary Embolism Market Through 2030?

The pulmonary embolism market has shown considerable growth in recent years. It is anticipated to expand from $2.26 billion in 2025 to $2.53 billion in 2026, driven by a compound annual growth rate (CAGR) of 12.0%. Factors contributing to its historical growth include the rising prevalence of cardiovascular and thromboembolic disorders, the expansion of hospital emergency care services, broader application of anticoagulant medications, increased recognition of pulmonary embolism symptoms, and the accessibility of advanced diagnostic imaging.

The pulmonary embolism market size is poised for substantial expansion over the next few years, with projections indicating it will reach $4.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.1%. This anticipated growth during the forecast period is fueled by increasing investments in advanced anticoagulant drugs, the rising adoption of catheter-based intervention techniques, the expansion of early diagnostic screening programs, a growing focus on outpatient management strategies, and an increasing demand for personalized cardiovascular care. Prominent trends throughout this period involve the increasing adoption of novel anticoagulant therapies, the rising use of minimally invasive thrombectomy devices, a growing emphasis on early and accurate diagnosis, the expansion of integrated care pathways, and an enhanced focus on risk stratification and prevention.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13026&type=smp

What Market Drivers Are Helping Shape The Pulmonary Embolism Market Expansion?

The rising incidence of cancer is anticipated to fuel expansion in the pulmonary embolism market. Cancer encompasses a range of diseases characterized by the uncontrolled and atypical proliferation of cells throughout the body. A higher occurrence of cancer elevates the likelihood of blood clot formation, such as pulmonary embolism, in affected individuals. This subsequently generates increased demand for diagnostic tools and treatment options, including specific medications. As an illustration, in January 2024, data from the American Cancer Society, a US-based nonprofit cancer advocacy organization, showed that cancer cases rose to 2,001,140 from 1,958,310 in 2023, indicating a 2.19% increase. Consequently, the growing prevalence of cancer is a key factor boosting the pulmonary embolism market.

How Is The Pulmonary Embolism Market Distributed Across Key Segments?

The pulmonary embolism market covered in this report is segmented –

1) By Treatment: Medications, Mechanical Devices, Other Treatments

2) By Diagnosis: Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography Scan, Pulmonary Angiography, Venography, Venous Ultrasound, D-Dimer Test, Other Diagnosis

3) By Symptoms: Shortness Of Breath, Chest Pain, Cough, Irregular Heartbeat, Dizziness, Fever, Cyanosis, Other Symptoms

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Medications: Anticoagulants, Thrombolytics

2) By Mechanical Devices: Inferior Vena Cava (IVC) Filters, Catheter-Assisted Thrombectomy

3) By Other Treatments: Surgical Embolectomy, Supportive Care

Which Trends Are Influencing The Expansion Of The Pulmonary Embolism Market?

Key organizations within the psychosis market are prioritizing the development of sophisticated patient feedback and data collection programs to refine service design, inform policy decisions, and foster care focused on recovery. Patient-voice initiatives empower individuals with personal experiences and their families to directly convey their needs, obstacles, and outcomes through structured surveys and research, thereby supporting evidence-based advocacy and more effective system reforms. For instance, in November 2025, Shine, an Ireland-based national mental health organization, in partnership with Mental Health Reform, an Ireland coalition on mental health, and the HSE National Clinical Programme for Early Intervention in Psychosis (EIP), introduced the 2025 National Survey of the Experiences of People Living with Psychosis. This effort gathers direct insights from people with psychosis and their families to uncover real-world experiences in obtaining care, illuminate systemic shortcomings and stigma, and guide improvements in national policy, investment in specialized early intervention services, and the expansion of community-based and crisis support alternatives.

Which Companies Form The Competitive Landscape Of The Pulmonary Embolism Market?

Major companies operating in the pulmonary embolism market are Pfizer Inc., Johnson And Johnson Private Limited, F Hoffmann La Roche Ltd., Merck And Co Inc., Novartis AG, Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, GSK plc, Abbott Laboratories, AstraZeneca plc, Medtronic plc, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Mitsubishi Tanabe Pharma Corporation, Genentech Inc., Hikma Pharmaceuticals plc, Aspen Pharmacare Holdings Limited, Nippon Shinyaku Co. Ltd., Fresenius Kabi AG, Inari Medical Inc., AngioDynamics Inc., Otsuka Pharmaceutical Co. Ltd., CSL Behring GmbH, Grifols S.A., Octapharma AG, Kedrion S.p.A

Access The Complete Pulmonary Embolism Market Report:

https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report

Which Regional Market Leads The Pulmonary Embolism Market?

North America was the largest region in the pulmonary embolism market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pulmonary embolism market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pulmonary Embolism Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=13026&type=smp

Browse Through More Reports Similar to the Global Pulmonary Embolism Market 2026, By The Business Research Company

Psychiatrists Market 2026

https://www.thebusinessresearchcompany.com/report/psychiatrists-market

Oncologists Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Mental Health Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/mental-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795